World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
47
Citations
13197
World Ranking
4472
National Ranking
2023

John R. Teijaro publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where John R. Teijaro sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 147 publications — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

John R. Teijaro D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where John R. Teijaro sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 47 D-Index — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

John R. Teijaro is a researcher affiliated with the Scripps Research Institute in the United States. Their work spans multiple fields, primarily focusing on medicine, immunology and microbiology, and biochemistry, genetics, and molecular biology. The subfields of study include immunology, infectious diseases, molecular biology, oncology, and genetics.

The research topics that John R. Teijaro addresses include:

  • SARS-CoV-2 and COVID-19 research
  • Immune cell function and interaction
  • Interferon and immune responses
  • T-cell and B-cell immunology
  • Immune response and inflammation
  • Immunotherapy and immune responses
  • COVID-19 clinical research studies

Frequent coauthors in their publications are:

  • Namir Shaabani
  • Jaroslav Žák
  • Isaraphorn Pratumchai
  • Vincent F. Vartabedian
  • Dennis R. Burton

John R. Teijaro has published extensively in several venues, among which the most frequent are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Immunology
  • Cancer Research
  • Science
  • Nature Chemical Biology

Selected recent papers include:

  • Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model, 2020, Science
  • COVID-19 vaccines: modes of immune activation and future challenges, 2021, Nature Reviews. Immunology
  • Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic, 2020, Science
  • Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation, 2021, Immunity
  • An Activity-Guided Map of Electrophile-Cysteine Interactions in Primary Human T Cells, 2020, Cell

Best Publications

  • Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model.

    Thomas F. Rogers;Thomas F. Rogers;Fangzhu Zhao;Deli Huang;Nathan Beutler

  • Proteome-wide covalent ligand discovery in native biological systems

    Keriann M. Backus;Bruno E. Correia;Kenneth M. Lum;Stefano Forli

  • Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling

    John R. Teijaro;Cherie Ng;Andrew M. Lee;Brian M. Sullivan

  • Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection

    John R. Teijaro;Kevin B. Walsh;Stuart M. Cahalan;Daniel M. Fremgen

  • Cutting Edge: Tissue-Retentive Lung Memory CD4 T Cells Mediate Optimal Protection to Respiratory Virus Infection

    John R. Teijaro;Damian Turner;Quynh Pham;E. John Wherry

  • COVID-19 vaccines: modes of immune activation and future challenges.

    John R Teijaro;Donna L Farber

  • Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic

    Emily N. Chin;Chenguang Yu;Chenguang Yu;Vincent F. Vartabedian;Ying Jia

  • Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation.

    Hongxu Xian;Yuan Liu;Alexandra Rundberg Nilsson;Raphaella Gatchalian

  • An Activity-Guided Map of Electrophile-Cysteine Interactions in Primary Human T Cells.

    Ekaterina V. Vinogradova;Xiaoyu Zhang;David Remillard;Daniel C. Lazar

  • PAD4-Mediated Neutrophil Extracellular Trap Formation Is Not Required for Immunity against Influenza Infection

    Saskia Hemmers;John R. Teijaro;Sanja Arandjelovic;Kerri A. Mowen

  • Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus

    Kevin B. Walsh;John R. Teijaro;Peter R. Wilker;Anna Jatzek

  • Type I interferons in viral control and immune regulation.

    John R Teijaro

  • A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection

    Unknown

  • Costimulation Modulation Uncouples Protection from Immunopathology in Memory T Cell Responses to Influenza Virus

    John R. Teijaro;Modesta N. Njau;David Verhoeven;Smita Chandran

  • Mapping the innate signaling cascade essential for cytokine storm during influenza virus infection

    John R. Teijaro;Kevin B. Walsh;Stephanie Rice;Hugh Rosen

  • Memory CD4 T Cells Direct Protective Responses to Influenza Virus in the Lungs through Helper-Independent Mechanisms

    John R. Teijaro;David Verhoeven;Carly A. Page;Damian Turner

  • GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches.

    Frederick M. Lang;Kevin M.-C. Lee;John R. Teijaro;Burkhard Becher

  • MicroRNAs of the miR-17 ∼ 92 family are critical regulators of T FH differentiation

    Seung Goo Kang;Wen-Hsien Liu;Peiwen Lu;Hyun Yong Jin

  • Blockade of Interferon Beta, but Not Interferon Alpha, Signaling Controls Persistent Viral Infection

    Cherie T. Ng;Brian M. Sullivan;John R. Teijaro;Andrew M. Lee

  • Chemical proteomic map of dimethyl fumarate–sensitive cysteines in primary human T cells

    Megan M. Blewett;Jiji Xie;Balyn W. Zaro;Keriann M. Backus

  • Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo

    Q M Nhu;K Shirey;J R Teijaro;D L Farber

  • Control of Memory CD4 T Cell Recall by the CD28/B7 Costimulatory Pathway

    Modesta P. Ndejembi;John R. Teijaro;Deepa S. Patke;Adam W. Bingaman

  • Cutting Edge: B Cell-Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection.

    Burton E. Barnett;Ryan P. Staupe;Pamela M. Odorizzi;Olesya Palko

Frequent Co-Authors

Michael B. A. Oldstone
Michael B. A. Oldstone Scripps Research Institute
Donna L. Farber
Donna L. Farber Columbia University
Hugh Rosen
Hugh Rosen Scripps Research Institute
Juan Carlos de la Torre
Juan Carlos de la Torre Scripps Research Institute
Benjamin F. Cravatt
Benjamin F. Cravatt Scripps Research Institute
Dennis R. Burton
Dennis R. Burton Scripps Research Institute
David Nemazee
David Nemazee Scripps Research Institute
Peter G. Schultz
Peter G. Schultz Scripps Research Institute
Karl S. Lang
Karl S. Lang University of Duisburg-Essen
Stefanie N. Vogel
Stefanie N. Vogel University of Maryland, Baltimore

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can broaden career opportunities. Nursing specialties, particularly Psychiatric Mental Health Nurse Practitioner (PMHNP) programs, are popular paths that complement immunology knowledge. Students often seek easiest NP programs to get into as a starting point, balancing accessibility with quality education.

Online PMHNP programs with strong clinical placement support are essential for real-world experience. Identifying PMHNP programs online with best clinical placement ensures that students gain hands-on skills crucial for advanced practice roles in immunology-related healthcare fields.

Cost is another significant factor when selecting a degree. Many students look for affordable PMHNP programs to pursue education without excessive financial burden while maintaining accreditation and quality standards.

Career advancement often involves pursuing a Doctor of Nursing Practice (DNP) degree. Specialty areas recognized for high compensation highlight the value of advanced degrees. Reviewing highest paid DNP specialties can guide students toward lucrative and impactful career pathways aligning with immunology expertise.

Best Scientists Citing John R. Teijaro

Trending Scientists

Recently Published Articles